Latest Form 4 insider transactions

Bruce C Cozadd, a Director of Jazz Pharmaceuticals plc, received 1,605 shares of common stock on August 5, 2026.

Shawn Tabak, CHIEF FINANCIAL OFFICER of Porch Group, Inc., sold 25,000 shares of common stock on August 5, 2026 for $16.21 per share.

Andrew Bednar, Chairman and CEO and a Director of Perella Weinberg Partners, sold 235,697 shares of common stock on August 5, 2026.

Kensington Capital Acquisition Corp. VI and Nth Cycle, Inc. have confidentially submitted a draft registration statement on Form S-4 with the SEC, marking a key step towards their proposed business combination.

Marc N Casper, Chairman & CEO and a Director of Thermo Fisher Scientific Inc., sold 15,000 shares of common stock on August 6, 2026.

Kenneth Bryan Dart, a 10% owner of Flutter Entertainment plc, purchased 1,703,715 shares of common stock on August 5, 2026.

Marc N Casper, Chairman & CEO and a Director of Thermo Fisher Scientific Inc., sold 15,000 shares of common stock on August 5, 2026.

Pablo G. Legorreta, CEO, Chairman of the Board and a Director of Royalty Pharma plc, reported multiple transactions in common stock on August 5, 2026.

Terrance P. Coyne, EVP & CFO of Royalty Pharma plc, reported multiple transactions in common stock on August 5, 2026.

Michelangelo Volpi, a Director of Aurora Innovation, Inc., sold 179,782 shares of common stock on August 5, 2026 for $7.07 per share.

John T Cahill, a Director of Colgate Palmolive Co, sold 4,170 shares of common stock on August 6, 2026 for $93.37 per share.

Patrick R. Gruber, a Director of Gevo, Inc., sold 247,642 shares of common stock on August 6, 2026 for $1.51 per share.

Kimberly T Bowron, Chief of Staff of Gevo, Inc., sold 10,257 shares of common stock on August 6, 2026 for $1.55 per share.

Michael Deveau, EVP, CFO of International Flavors & Fragrances Inc, sold 8,825 shares of common stock on August 6, 2026 for $85.55 per share.

M Farooq Kathwari, Chairman, President & CEO and a Director of Ethan Allen Interiors Inc, reported multiple transactions in common stock on August 5, 2026.

Oluwagbemileke Yusuf Agiri, CFO of Gevo, Inc., sold 18,223 shares of common stock on August 6, 2026 for $1.54 per share.

Paul D Bloom, CEO and a Director of Gevo, Inc., sold 31,096 shares of common stock on August 6, 2026 for $1.55 per share.

Thomas Kosasa, a Director and 10% owner of OneMedNet Corp, purchased 1,449,275 shares of common stock on July 30, 2026 for $0.69 per share.

Christopher A Kuebler, a Director of Waters Corp /De/, sold 3,626 shares of common stock on August 6, 2026 for $397.94 per share.

John H Batten, President and CEO, a Director and 10% owner of Twin Disc Inc, reported multiple transactions in common stock on August 5, 2026.

Jeffrey Scott Knutson, VP Finance, CFO, Secr & Trea of Twin Disc Inc, reported multiple transactions in common stock on August 5, 2026.

Patrick Thomas Ellinor Ii, a Director of Editas Medicine, Inc., received 103,400 shares of common stock on August 6, 2026.

Murray R Garnick, a Director of Cronos Group Inc., received 48,860 shares of common stock on August 6, 2026.

James Daniel Rudyk, a Director of Cronos Group Inc., received 48,860 shares of common stock on August 6, 2026.

Sean Patrick Buckley, See Remarks of Magnite, Inc., sold 67,179 shares of common stock on August 6, 2026.

Paul F. Lizzul, Chief Medical Officer of Anaptysbio, Inc, received 16,667 shares of common stock on March 12, 2026.

Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc, received 11,002 shares of common stock on August 5, 2026.

Daniel Faga, President, CEO and a Director of Anaptysbio, Inc, received 53,334 shares of common stock on March 12, 2026.

Frank P. Stewart, SVP, Advanced Cellular of Qorvo, Inc., reported a transaction in 2,262 shares of common stock on August 5, 2026.

Gina Harrison, VP and Corporate Controller of Qorvo, Inc., reported a transaction in 534 shares of common stock on August 5, 2026.